The disposition of sulfoxone and solasulfone in leprosy patients.
D000476:Alkanesulfonates / Q000378:metabolism* / Q000627:therapeutic use; D003622:Dapsone / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007917:Leprostatic Agents / Q000378:metabolism* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy / Q000378:metabolism*; D013450:Sulfones / Q000378:metabolism* / Q000627:therapeutic use
D000476:Alkanesulfonates; D007917:Leprostatic Agents; D013450:Sulfones; D003622:Dapsone; C009799:solasulfone